Patient Square Capital
Overview
Patient Square Capital is a dedicated health care investment firm that partners with management teams whose products, services, and technologies improve health.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| hanger, inc. | Oct 2022 | Take Private | Lead |
| CAMP4 | Jul 2022 | Series B | Co-investor |
| Apollo Therapeutics | Dec 2023 | Series C Extension | Lead |
| Nuclera | Jan 2026 | Series C Extension | Co-investor |
| Osanni Bio | Jun 2026 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Adam Fliss
Founding Partner and General Counsel
Neel Varshney
Founding Partner
Kaveh Samie
Partner, Chairman And CEO Of MENA And Head Of International Fund Partnerships
Jim Momtazee
Managing Partner
Rebecca Marty
EA To Managing Partner
Chris Wade
Partner
Emily Janvey
Partner, Co-Head Of Royalty And Structured Solutions
Jason Ridloff
Partner
Laura Furmanski
Partner and Head of Patient Square Insights
Russell Chong
Partner
Hannah Carlino
Vice President
Patrick Martin
Principal
Brendan Wu
Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Patient Square Capital based?
Patient Square Capital is headquartered in Menlo Park, California, United States.
When was Patient Square Capital founded?
Patient Square Capital was founded in 2020.
How many portfolio companies does Patient Square Capital have?
Patient Square Capital has 19 portfolio companies in Caplight's dataset.
What are some companies in Patient Square Capital's portfolio?
Portfolio companies visible on Caplight include hanger, inc., CAMP4, Apollo Therapeutics, Nuclera, Osanni Bio.
What was Patient Square Capital's most recent investment shown here?
Patient Square Capital's most recent investment in this portfolio sample was in Osanni Bio in 2026.
What sectors does Patient Square Capital focus on?
Patient Square Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Media, Entertainment & Gaming, Enterprise Software, Consumer & Commerce, Consumer & Commerce, Consumer & Commerce, Enterprise Software.
What company stages does Patient Square Capital focus on?
Patient Square Capital typically invests at the Mid stage.
What is Patient Square Capital's AUM?
Patient Square Capital's assets under management are estimated between $17.5B and $19.0B.